NATCO PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Natco Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.64₹ 13.9
As on Sep 12, 2025, 4:01 PM IST
Natco Pharma Price Performance
Today's LowToday's High
₹850.30₹863.80
₹862.30
52 Weeks' Low52 Weeks' High
₹660.05₹1,638.35
₹862.30
Open Price
₹858.25
Prev. Close
₹848.40
Volume
44,351
Over the last 5 years, the share price of Natco Pharma has gained 2.00% CAGR. Over the past year, the corresponding return has been -45.86%.
Natco Pharma’s current P/E of 9.10x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Natco Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Natco Pharma | 1.07 | -4.63 | -5.51 | 10.44 | -45.52 | 12.68 | 2 |
| Sun Pharmaceutical Industries | 0.97 | -1.8 | -4.65 | -4.38 | -13.15 | 21.98 | 26.56 |
| Divi's Laboratories | 0.07 | -1.47 | -9.84 | 7.01 | 9.43 | 17.82 | 13.69 |
| Cipla | 1.32 | 0.77 | 4.54 | 7.68 | -5.15 | 13.91 | 16.87 |
| Torrent Pharmaceuticals | -0.56 | -1.6 | 9.51 | 16.4 | 3.02 | 33.17 | 20.55 |
| Dr. Reddy's Laboratories | 3.77 | 5.1 | -3.31 | 18.82 | -1.15 | 15.58 | 8.56 |
| Mankind Pharma | 1.25 | 4.79 | 8.46 | 17.37 | 3.39 | 21.96 | 12.65 |
| Zydus Lifesciences | 3.03 | 5.64 | 7.16 | 18.39 | -6.58 | 40.52 | 23.17 |
| Lupin | 5.05 | 2.7 | 2.13 | 3.75 | -9.35 | 44.9 | 16.11 |
| Abbott India | -0.3 | -5.76 | -1.46 | 4.98 | 5.15 | 19.7 | 13.47 |
| Alkem Laboratories | 1.96 | 0.93 | 12.23 | 15.67 | -14.48 | 19.3 | 13.34 |
| Aurobindo Pharma | 4.78 | 1.59 | -4.9 | -0.03 | -30.19 | 25.7 | 6.59 |
| Glenmark Pharmaceuticals | 3.46 | 4.57 | 27.25 | 51.3 | 21.25 | 75.97 | 34.52 |
| Biocon | 0.26 | 1.26 | 2.62 | 12.96 | -3.71 | 6.33 | -3.24 |
| Laurus Labs | 1.7 | 3.77 | 34.34 | 56.25 | 77.18 | 17.9 | 27.44 |
| GlaxoSmithKline Pharmaceuticals | 0.17 | 0.05 | -15.89 | 4.42 | -4.41 | 24.98 | 9.94 |
| Anthem Biosciences | 0.28 | 10.26 | 13.93 | 13.93 | 13.93 | 4.44 | 2.64 |
| Cohance Lifesciences | 5.6 | -1.14 | -2.9 | -14.86 | -19.22 | 26.94 | 21.87 |
| Ipca Laboratories | -1.62 | -3.7 | -3.91 | 1.17 | -11.01 | 14.5 | 4.09 |
| Gland Pharma | 6.68 | 3.57 | 19.57 | 29.97 | 7.58 | -5.1 | 2.1 |
Over the last one year, Natco Pharma has declined 45.52% compared to peers like Sun Pharmaceutical Industries (-13.15%), Divi's Laboratories (9.43%), Cipla (-5.15%). From a 5 year perspective, Natco Pharma has underperformed peers relative to Sun Pharmaceutical Industries (26.56%) and Divi's Laboratories (13.69%).
Natco Pharma Financials
Natco Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 848.51 | 848.91 |
| 10 | 857.49 | 855.35 |
| 20 | 869.62 | 870.91 |
| 50 | 931.16 | 896.9 |
| 100 | 898.75 | 920.17 |
| 200 | 1,008.01 | 979.39 |
Natco Pharma Share Holding Pattern
In the latest quarter, Natco Pharma remained same as its previous close in promoter holding, while DII stake increased to 5.81%, FII holding fell to 15.52%, and public shareholding moved up to 29.12% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Natco Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| Tata Equity P/E Fund - Regular Plan | 15,75,400 | 1.74 | 150.2 |
| Tata Equity P/E Fund - Regular Plan - Trigger Option A 5% | 15,75,400 | 1.74 | 150.2 |
| Sundaram Small Cap Fund | 5,61,369 | 1.58 | 53.52 |
| Tata Small Cap Fund | 5,49,064 | 0.45 | 52.35 |
| Nippon India Nifty Smallcap 250 Index Fund | 1,13,670 | 0.44 | 10.84 |
| Nippon India Nifty Pharma ETF | 1,03,114 | 1.04 | 9.83 |
| Axis Nifty Smallcap 50 Index Fund | 69,721 | 1.27 | 6.65 |
| SBI Nifty Smallcap 250 Index Fund | 68,486 | 0.44 | 6.53 |
| Baroda BNP Paribas Business Cycle Fund | 58,500 | 0.96 | 5.58 |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 44,477 | 0.44 | 4.24 |
Natco Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 10, 2025, 4:53 PM IST | Natco Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 04, 2025, 6:26 AM IST | Natco Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Aug 30, 2025, 12:02 AM IST | Natco Pharma - Business Responsibility and Sustainability Reporting (BRSR) |
| Aug 30, 2025, 12:01 AM IST | Natco Pharma - Notice Of 42Nd Annual General Meeting |
| Aug 29, 2025, 11:41 PM IST | Natco Pharma - Reg. 34 (1) Annual Report. |
About Natco Pharma
Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1981PLC003201 and registration number is 003201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 4094.50 Cr. and Equity Capital is Rs. 35.80 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressNATCO House, Road # 2, Banjara Hills, Hyderabad Telangana 500034
- Contact
Management
- Mr. V C NannapaneniChairman & Ind.Director
- Mr. Rajeev NannapaneniDirector & CEO
- Mr. P S R K PrasadDirector & Exe. VP (Corp. Engg. Services)
- Dr. D Linga RaoDirector & President (Tech. Affairs)
- Dr. Pavan Ganapati BhatDirector
- Mr. D Vijaya BhaskarIndependent Director
- Mr. A D M ChavaliIndependent Director
- Dr. Kantipudi SumaAddnl. & Ind.Director
- Mr. Nitin JainAddnl. & Ind.Director
- Mr. Lakshminarayana BolisettyAddnl. & Ind.Director
FAQs on Natco Pharma Share Price
What is the share price of Natco Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Natco Pharma is ₹862.30 as on Sep 12, 2025.
What kind of stock is Natco Pharma?
The Natco Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Natco Pharma?
The market cap of Natco Pharma is ₹15,444.64 Cr as on Sep 12, 2025.
What are today's High and Low prices of Natco Pharma?
Today’s highest and lowest price of Natco Pharma are ₹863.80 and ₹850.30.
What are the 52 Week High and 52 Week Low of Natco Pharma?
The 52-week high/low is the highest and lowest price at which Natco Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Natco Pharma is ₹1,638.35 and 52-week low of Natco Pharma is ₹660.05 as on Sep 12, 2025.
How has the Natco Pharma performed historically in terms of returns?
The Natco Pharma has shown returns of 1.64% over the past day, -2.88% for the past month, -6.69% over 3 months, -45.86% over 1 year, 12.68% across 3 years, and 2.0% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Natco Pharma?
P/E ratio of and PB ratio of Natco Pharma are 9.10 and 2.03 on Sep 12, 2025. While the company gives a dividend yield of 0.70 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data